Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a well-defined entity. Dupilumab was the first authorized drug for effective treatment of CRSwNP. Nevertheless, it may lead to side effects including an increase in the absolute eosinophil count.
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: